By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antisense Therapeutics Limited 

Level 1
10 Wallace Avenue
Toorak  Victoria  3142  Australia
Phone: 61-3-9827-8999 Fax: 61-3-9827-1166


SEARCH JOBS


Industry
Pharmaceutical






Company News
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014 9:00:25 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Recruitment Completed 3/21/2014 10:43:28 AM
Antisense Therapeutics Limited (ANP.AX) Selected To Present At Biotech Showcase™ 2014 1/8/2014 6:51:53 AM
Antisense Therapeutics Limited (ANP.AX) Release: Positive Results Achieved From Interim Analysis Of ATL1103 Phase II Trial 12/23/2013 9:31:41 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 for Multiple Sclerosis -Toxicology Study to Commence 5/2/2013 1:42:18 PM
Antisense Therapeutics Limited (ANP.AX) and TJAB Advance MS Drug 3/19/2013 2:45:04 PM
Antisense Therapeutics Limited (ANP.AX) Announces ATL1103 on Track to Move Into Clinical Development 10/13/2009 10:18:13 AM
Antisense Therapeutics Limited (ANP.AX) to Present at Rodman & Renshaw 11th Annual Healthcare Conference 8/31/2009 10:15:12 AM
Antisense Therapeutics Limited (ANP.AX) Drug ATL1101 Enhances Effect of Existing Chemotherapy Treatment on Prostate Tumors 6/18/2009 10:13:33 AM
Antisense Therapeutics Limited (ANP.AX) to Present at Rodman & Renshaw 10th Annual Healthcare Conference 10/27/2008 10:00:31 AM
123
//-->